Aurinia Pharmaceuticals Inc. buy BiotechBee
Start price
04.01.23
/
60%
€6.46
Target price
31.12.25
€12.00
Performance (%)
63.49%
End price
05.05.23
€10.56
Summary
This prediction ended on 05.05.23 with a price of €10.56. With a performance of 63.49% the BUY prediction by BiotechBee was a big success. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | 2.790% | 2.790% | 93.542% | 41.838% |
| iShares Core DAX® | -0.201% | 5.471% | 9.188% | 48.662% |
| iShares Nasdaq 100 | 2.573% | 10.092% | 39.291% | 95.716% |
| iShares Nikkei 225® | 0.598% | 9.871% | 46.201% | 63.770% |
| iShares S&P 500 | 1.804% | 7.404% | 29.617% | 67.241% |
According to BiotechBee what are the pros and cons of Aurinia Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Aurinia Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 12,0
In the thread Trading Aurinia Pharmaceuticals Inc.
Buy beendet

